Cargando…

Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes

PURPOSE: To compare the immunogenicity and efficacy of insulin glargine biosimilar Ezelin (EZL) versus originator insulin glargine Lantus (LAN) as a reference basal insulin in patients with type 2 diabetes (T2D). PATIENTS AND METHODS: This was a randomized, multicenter, open-label, 24-week study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarigan, Tri Juli Edi, Dwijayanti, Adisti, Setyowati, Susie, Louisa, Melva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811452/
https://www.ncbi.nlm.nih.gov/pubmed/33469328
http://dx.doi.org/10.2147/DMSO.S279385